Latest Medtech Investment News

Tetratherix Limited has raised approximately $5 million to fast-track its Tutelix prostate spacer into pivotal clinical trials across Australia and the US, aiming to improve radiation therapy for prostate cancer patients.

Rewardle Holdings has cleared a major compliance hurdle by releasing its preliminary report, spotlighting its strategic investment in cardiac MedTech firm CloudHolter and ongoing B2B2C platform development.